Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing
K Bruce, K Bharti, I Barbaric et al
Achieving rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study
M Dingle, A Carwell, M J. Miller et al
GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing
Lili Belcastro, Basak Clements, Claire Wartel
Modernizing viral clearance study strategy: regulatory updates and industry best practices
Audrey Chang, Kathleen Kenney
From concept to clinic: overcoming the challenges of potency assays in cell and gene therapy development
Audrey Chang, Joe Newcome
Emerging global trends and regulatory opportunities in cell therapies for cancer
Kim Watanabe, Sushama Sankpal, Kasey Kime
Revolutionizing cell and gene therapy with digitalization: a panel discussion with industry leaders
Caitlin Harrison, Rebecca Street-Howards, Kanchan Deshpande
Preventing cross-contamination in cell therapy production
Josh Ludwig, Mary Kay Bates
Considerations in leveraging the Universal AAV Standard for dPCR to assess AAV genomes quantity and quality
Andrzej Noyszewski, Alex Deiulio
